Balanced news tone
News Sentiment
INCR sentiment intelligence
InterCure Ltd. news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
86/100 classification confidence.
directly relevant articles
high-authority source matches
-7.8% over one week, +5.6% over four weeks, trend inactive, and below fair value.
Intercure Ltd. (INCR) Slides 3% as Support at $0.90 Comes Into Focus - Fibonacci Entry Signals
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Intercure Ltd. (INCR) Slides 3% as Support at $0.90 Comes Into Focus - Fibonacci Entry Signals
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jul 2026 07:00
- Source
- dars.gov.et
InterCure raises NIS 22M, with room to reach NIS 54M
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
InterCure Secures NIS 22 Million Private Placement With Potential to Rise to NIS 54 Million for Global Expansion
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Quiver Quantitative
InterCure (NASDAQ: INCR) lines up NIS 22–54 million private placement funding
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- Stock Titan
InterCure Secures NIS 22 Million in Private Placement Financing Led by Leading Pharma-Focused Hedge Funds
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Jun 2026 07:00
- Source
- GlobeNewswire
U.S. cannabis shift prompts InterCure rethink and new launches in Germany
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 15 Jun 2026 07:00
- Source
- Stock Titan
InterCure Initiates Strategic Review of U.S. Medical
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 07:00
- Source
- GlobeNewswire
InterCure Ltd. Completes First Tranche of Botanico Acquisition to Enhance International Medical Cannabis Platform
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 15 Jun 2026 07:00
- Source
- Quiver Quantitative
Intercure Ltd. (INCR) Holds Near Support as Modest Gains Signal Stabilization Attempt - PCR Extreme
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 12 Jun 2026 07:00
- Source
- dars.gov.et
InterCure Announces 2025 Results with NIS 270 Million in Revenue and Positive Operating Cash Flow
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- GlobeNewswire
Intercure LTD (INCR) Releases Q4 2025 Earnings: Revenue Up 43.8% but Company Remains Unprofitable
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 30 Apr 2026 07:00
- Source
- Quiver Quantitative
InterCure Receives Nasdaq Notification Regarding Minimum Bid Requirement
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Mar 2026 08:00
- Source
- GlobeNewswire
InterCure to Acquire ISHI, Unlocking Access to Premium US Cannabis Technology, Brands
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 19 Sep 2025 07:00
- Source
- Cannabis Business Times
InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 20 Dec 2024 08:00
- Source
- PR Newswire
Intercure becomes tenth TASE medical cannabis co - Globes
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2018 07:00
- Source
- Israel Business News